Reproductive Health

Federal Judge Rules to Reverse FDA Approval of Abortion Pill

by Veronica Salib

On Friday, April 7, 2023, a federal judge in Texas ruled to reverse the approval of mifepristone, the abortion pill. The Trump-appointed judge, Mathew Kacsmaryk, was assigned to the Alliance for...

Behind Walgreens’ Decision to Forgo Abortion Pill Distribution in Some States

by Hayden Schmidt

Last week, Walgreens announced that it would no longer distribute abortion pills in 20 states across the US following legal warnings made by the attorneys general of those states. Specifically,...

FDA Expands Access to Abortion Pills in Retail Pharmacies

by Veronica Salib

In a step towards widening access, the FDA made a regulatory change, allowing the abortion pill, mifepristone, to be distributed by retail pharmacies with a valid prescription. Mifepristone is one...

Naloxone Vending Machines Prevented Almost 1,000 Deaths

by Veronica Salib

Based on data from the CDC, since 1999, there have been nearly one million overdose-related deaths. In 2020, the United States reported 91,799 overdose deaths, a 31% increase from the previous year....

Comparing Buprenorphine and Methadone for OUD During Pregnancy

by Veronica Salib

Data from the CDC suggests that 75% of overdoses in the United States involve opioids. It is abundantly clear to healthcare professionals that the rates of opioid use disorder (OUD) are rising —...

Wound Infiltration May Reduce Pain Following Cesarean Delivery

by Veronica Salib

In an article published in JAMA Network Open by Gali Garmi, MD, and his colleagues state that cesarean delivery — commonly referred to as a C-section — is the most common abdominal surgery...

COVID-19 Vaccination Alters Menstrual Cycle Length

by Veronica Salib

As the COVID-19 pandemic continues and vaccinations continue to be advanced, many patients are concerned about vaccine side effects. Multiple sources have perpetuated the misconception that COVID-19...

Gates Foundation Funds Refillable Birth Control Development

by Veronica Salib

The Bill and Melinda Gates Foundation recently granted $625,803 to Celanese — a chemical company focused on chemical intermediates, engineered materials, polymers, emulsions, and specialty food ingredients — to research and...

IVF Provides Additional Resources in Reproductive Health

by Veronica Salib

The overturning of Roe v. Wade in the 2022 Dobbs v. Jackson Women’s Health Organization United State Supreme Court case has brought about a lot of conversation about reproductive rights, including in vitro fertilization (IVF). The...

FDA Approves Mirena for 8 Years

by Veronica Salib

Alongside Kyleena and Liletta, Mirena is one of three hormonal intrauterine devices (IUD) available in the United States. Previously, the duration of use for Mirena was seven years, at which point the...

Hormonal Male Birth Control Product Reaches Late-Phase Clinical Trials

by Veronica Salib

The only male forms of birth control currently available are condoms and vasectomies. With a limited choice in male birth control, contraception typically falls on the child-bearing individual. This...

Limited Access to Female Contraceptives: A Public Health Crisis

by Veronica Salib

Unintended pregnancy threatens public health and is exacerbated by limited access and understanding of female contraceptives. The CDC identifies unintended pregnancy as “a pregnancy that is either unwanted, such as the...

Aid Access Discusses Making Abortion Pill Available as Contraception

by Veronica Salib

In an interview with Democracy Now, Rebecca Gomperts, MD, mentioned plans to make mifepristone, the abortion pill, available as a weekly or emergency contraceptive. Gomperts is the founder of Aid...

HHS Issues Pharmacies’ Obligation to Ensure Access to Reproductive Care

by Veronica Salib

The overturning of Roe v. Wade by the United States Supreme Court has left many people anxious about access to reproductive healthcare. Earlier this week, the HHS established guidelines for retail...

HRA Pharma Submits FDA Application for First OTC Birth Control Pill

by Veronica Salib

HRA Pharma has submitted an FDA application to allow the OTC sale of their progestin-only daily birth control pill, Opill. If this application is approved, this will be the first birth control pill...